Y-mAbs Therapeutics Inc to Host Key Opinion Leader Webinar on DANYELZA® - Conference Call Transcript
Good afternoon, and welcome to the Y-mAbs Therapeutics KOL Webinar on DANYELZA frontline and HITS data in high-risk neuroblastoma. At this time, all attendees are in a listen-only mode. A live verbal question-and-answer session will follow today's formal presentation. This webinar is not being recorded, and there will be no replay made available following the conclusion of today's event.
I would now like to turn the call over to your host, Thomas Gad, Chairman, Founder and President of Y-mAbs Therapeutics. Please go ahead, Thomas.
Thank you, Sara. Before we begin, let me just remind everyone that today contains -- today's discussion contains forward-looking statements as defined by the Reform Act of 1995, the disclaimers here. With that said, we are very pleased today to have Dr. Jaume Mora from Hospital Sant Joan de Deu in Barcelona, probably one of the biggest
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |